Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
FBRX | Forte Biosciences, Inc. | Riley Antony A | CHIEF FINANCIAL OFFICER | Oct 01, 2024 | Option Exercise | $5.16 | 133 | 686 | 8,262 | Oct 02, 2024, 06:21 PM | |
FBRX | Forte Biosciences, Inc. | Riley Antony A | CHIEF FINANCIAL OFFICER | Apr 01, 2024 | Option Exercise | $0.71 | 3,345 | 2,367 | 194,474 | Apr 02, 2024, 06:32 PM | |
FBRX | Forte Biosciences, Inc. | Riley Antony A | Chief Financial Officer | Jan 01, 2024 | Option Exercise | $0.82 | 3,841 | 3,156 | 188,444 | Jan 03, 2024, 04:02 PM | |
FBRX | Forte Biosciences, Inc. | Riley Antony A | Chief Financial Officer | Jul 31, 2023 | Option Exercise | $1.01 | 148,514 | 149,999 | 176,776 | Aug 02, 2023, 05:57 PM | |
FBRX | Forte Biosciences, Inc. | Riley Antony A | Chief Financial Officer | Jul 01, 2023 | Option Exercise | $1.04 | 3,241 | 3,371 | 24,762 | Jul 05, 2023, 04:06 PM | |
FBRX | Forte Biosciences, Inc. | Riley Antony A | Chief Financial Officer | Apr 01, 2023 | Option Exercise | $1.01 | 3,241 | 3,273 | 18,628 | Apr 04, 2023, 08:18 PM | |
FBRX | Forte Biosciences, Inc. | Riley Antony A | Chief Financial Officer | Sep 07, 2021 | Sale | $4.24 | 25,000 | 106,105 | 14,581 | Sep 07, 2021, 04:09 PM | |
FBRX | Forte Biosciences, Inc. | Riley Antony A | Chief Financial Officer | Jun 26, 2020 | Buy | $14.52 | 4,700 | 68,225 | 34,065 | Jun 30, 2020, 08:07 PM | |
FBRX | Forte Biosciences, Inc. | Riley Antony A | Chief Financial Officer | Jun 29, 2020 | Buy | $14.11 | 2,000 | 28,220 | 36,065 | Jun 30, 2020, 08:07 PM | |
KRYS | Krystal Biotech, Inc. | Riley Antony A | Chief Financial Officer | Nov 19, 2019 | Option Exercise | $9.85 | 6,250 | 61,563 | 9,050 | Nov 21, 2019, 04:05 PM | |
KRYS | Krystal Biotech, Inc. | Riley Antony A | Chief Financial Officer | May 22, 2018 | Buy | $10.75 | 2,800 | 30,100 | 2,800 | May 24, 2018, 05:28 PM |